BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23377826)

  • 1. Regulation of the kinase RSK1 by arsenic trioxide and generation of antileukemic responses.
    Galvin JP; Altman JK; Szilard A; Goussetis DJ; Vakana E; Sassano A; Platanias LC
    Cancer Biol Ther; 2013 May; 14(5):411-6. PubMed ID: 23377826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct binding of arsenic trioxide to AMPK and generation of inhibitory effects on acute myeloid leukemia precursors.
    Beauchamp EM; Kosciuczuk EM; Serrano R; Nanavati D; Swindell EP; Viollet B; O'Halloran TV; Altman JK; Platanias LC
    Mol Cancer Ther; 2015 Jan; 14(1):202-12. PubMed ID: 25344585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic in leukemia: a RSKy business.
    Dent P
    Cancer Biol Ther; 2013 Oct; 14(10):871-2. PubMed ID: 24025257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory effects of mammalian target of rapamycin-mediated signals in the generation of arsenic trioxide responses.
    Altman JK; Yoon P; Katsoulidis E; Kroczynska B; Sassano A; Redig AJ; Glaser H; Jordan A; Tallman MS; Hay N; Platanias LC
    J Biol Chem; 2008 Jan; 283(4):1992-2001. PubMed ID: 18048359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the p38 mitogen-activated protein kinase pathway in the generation of arsenic trioxide-dependent cellular responses.
    Giafis N; Katsoulidis E; Sassano A; Tallman MS; Higgins LS; Nebreda AR; Davis RJ; Platanias LC
    Cancer Res; 2006 Jul; 66(13):6763-71. PubMed ID: 16818652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of arsenic trioxide-induced cellular responses by Mnk1 and Mnk2.
    Dolniak B; Katsoulidis E; Carayol N; Altman JK; Redig AJ; Tallman MS; Ueda T; Watanabe-Fukunaga R; Fukunaga R; Platanias LC
    J Biol Chem; 2008 May; 283(18):12034-42. PubMed ID: 18299328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol enhances the suppressive effects of arsenic trioxide on primitive leukemic progenitors.
    Wu EJ; Goussetis DJ; Beauchamp E; Kosciuczuk EM; Altman JK; Eklund EA; Platanias LC
    Cancer Biol Ther; 2014 Apr; 15(4):473-8. PubMed ID: 24496081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to arsenic trioxide.
    Verma A; Mohindru M; Deb DK; Sassano A; Kambhampati S; Ravandi F; Minucci S; Kalvakolanu DV; Platanias LC
    J Biol Chem; 2002 Nov; 277(47):44988-95. PubMed ID: 12239215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic trioxide-dependent activation of thousand-and-one amino acid kinase 2 and transforming growth factor-beta-activated kinase 1.
    McNeer JL; Goussetis DJ; Sassano A; Dolniak B; Kroczynska B; Glaser H; Altman JK; Platanias LC
    Mol Pharmacol; 2010 May; 77(5):828-35. PubMed ID: 20159944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy is a critical mechanism for the induction of the antileukemic effects of arsenic trioxide.
    Goussetis DJ; Altman JK; Glaser H; McNeer JL; Tallman MS; Platanias LC
    J Biol Chem; 2010 Sep; 285(39):29989-97. PubMed ID: 20656687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of Mcl-1 through GSK-3β activation contributes to arsenic trioxide-induced apoptosis in acute myeloid leukemia cells.
    Wang R; Xia L; Gabrilove J; Waxman S; Jing Y
    Leukemia; 2013 Feb; 27(2):315-24. PubMed ID: 22751450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of arsenic trioxide (As2O3) on leukemic cells from patients with non-M3 acute myelogenous leukemia: studies of cytotoxicity, apoptosis and the pattern of resistance.
    Lehmann S; Bengtzen S; Paul A; Christensson B; Paul C
    Eur J Haematol; 2001 Jun; 66(6):357-64. PubMed ID: 11488934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the mitogen- and stress-activated kinase 1 by arsenic trioxide.
    Kannan-Thulasiraman P; Katsoulidis E; Tallman MS; Arthur JS; Platanias LC
    J Biol Chem; 2006 Aug; 281(32):22446-52. PubMed ID: 16762916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thioredoxin-1 inhibitor PX-12 induces human acute myeloid leukemia cell apoptosis and enhances the sensitivity of cells to arsenic trioxide.
    Tan Y; Bi L; Zhang P; Wang F; Lin F; Ni W; Wu J; Jiang L
    Int J Clin Exp Pathol; 2014; 7(8):4765-73. PubMed ID: 25197347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic trioxide affects signal transducer and activator of transcription proteins through alteration of protein tyrosine kinase phosphorylation.
    Wetzler M; Brady MT; Tracy E; Li ZR; Donohue KA; O'Loughlin KL; Cheng Y; Mortazavi A; McDonald AA; Kunapuli P; Wallace PK; Baer MR; Cowell JK; Baumann H
    Clin Cancer Res; 2006 Nov; 12(22):6817-25. PubMed ID: 17121903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells.
    Martelli MP; Gionfriddo I; Mezzasoma F; Milano F; Pierangeli S; Mulas F; Pacini R; Tabarrini A; Pettirossi V; Rossi R; Vetro C; Brunetti L; Sportoletti P; Tiacci E; Di Raimondo F; Falini B
    Blood; 2015 May; 125(22):3455-65. PubMed ID: 25795919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide-induced apoptosis in U937 cells involve generation of reactive oxygen species and inhibition of Akt.
    Choi YJ; Park JW; Suh SI; Mun KC; Bae JH; Song DK; Kim SP; Kwon TK
    Int J Oncol; 2002 Sep; 21(3):603-10. PubMed ID: 12168106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory Effects of Arsenic Trioxide and Thalidomide on Angiogenesis and Vascular Endothelial Growth Factor Expression in Leukemia Cells.
    Mohammadi Kian M; Mohammadi S; Tavallaei M; Chahardouli B; Rostami S; Zahedpanah M; Ghavamzadeh A; Nikbakht M
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):1127-1134. PubMed ID: 29699374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of mammalian target of rapamycin and the p70 S6 kinase by arsenic trioxide in BCR-ABL-expressing cells.
    Yoon P; Giafis N; Smith J; Mears H; Katsoulidis E; Sassano A; Altman J; Redig AJ; Tallman MS; Platanias LC
    Mol Cancer Ther; 2006 Nov; 5(11):2815-23. PubMed ID: 17121928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arsenic trioxide: impact on the growth and differentiation of cancer cells and possible use in cancer therapy].
    Hoffman E; Mielicki WP
    Postepy Hig Med Dosw (Online); 2013 Aug; 67():817-27. PubMed ID: 24018447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.